Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs
Crossref DOI link: https://doi.org/10.1007/s40266-015-0341-2
Published Online: 2016-01-30
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sugihara, Takahiko
Harigai, Masayoshi
Funding for this research was provided by:
a grant-in-aid from the Ministry of Health, Labor and Welfare, Japan (H26-meneki-shitei-21)
Takeda Pharmaceutical Co., Ltd
Astellas Pharma Inc.
Teijin Pharma Ltd
License valid from 2016-01-30